Isofol Medical AB (publ) (ISOFOL.ST)
SEK 1.78
(0.62%)
SEK 1.78
(0.62%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.23 SEK | 76.29% |
| 2022 | -0.97 SEK | 38.22% |
| 2021 | -1.57 SEK | 35.39% |
| 2020 | -2.43 SEK | 12.9% |
| 2019 | -2.79 SEK | -88.51% |
| 2018 | -1.48 SEK | 0.0% |
| 2017 | -1.48 SEK | 34.51% |
| 2016 | -2.26 SEK | -63.77% |
| 2015 | -1.38 SEK | 0.0% |
| 2011 | -1.53 SEK | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.07 SEK | -30.29% |
| 2024 Q1 | -0.05 SEK | 4.55% |
| 2023 Q4 | -0.06 SEK | -41.75% |
| 2023 FY | - SEK | 76.29% |
| 2023 Q1 | -0.09 SEK | 44.31% |
| 2023 Q2 | -0.05 SEK | 47.81% |
| 2023 Q3 | -0.04 SEK | 16.56% |
| 2022 Q2 | -0.32 SEK | -14.29% |
| 2022 FY | - SEK | 38.22% |
| 2022 Q1 | -0.28 SEK | 26.32% |
| 2022 Q4 | -0.16 SEK | 11.11% |
| 2022 Q3 | -0.18 SEK | 43.75% |
| 2021 Q4 | -0.38 SEK | -18.75% |
| 2021 FY | - SEK | 35.39% |
| 2021 Q1 | -0.40 SEK | 23.08% |
| 2021 Q2 | -0.48 SEK | -20.0% |
| 2021 Q3 | -0.32 SEK | 33.33% |
| 2020 Q3 | -0.29 SEK | 72.12% |
| 2020 Q4 | -0.52 SEK | -79.31% |
| 2020 FY | - SEK | 12.9% |
| 2020 Q1 | -1.38 SEK | -33.98% |
| 2020 Q2 | -1.04 SEK | 24.64% |
| 2019 FY | - SEK | -88.51% |
| 2019 Q4 | -1.03 SEK | 0.0% |
| 2019 Q1 | -0.48 SEK | 7.69% |
| 2019 Q3 | -1.03 SEK | -19.77% |
| 2019 Q2 | -0.86 SEK | -79.17% |
| 2018 Q4 | -0.52 SEK | -67.74% |
| 2018 FY | - SEK | 0.0% |
| 2018 Q2 | -0.30 SEK | 16.67% |
| 2018 Q1 | -0.36 SEK | 32.08% |
| 2018 Q3 | -0.31 SEK | -3.33% |
| 2017 Q3 | -0.41 SEK | -70.83% |
| 2017 FY | - SEK | 34.51% |
| 2017 Q1 | -0.45 SEK | 58.33% |
| 2017 Q2 | -0.24 SEK | 46.67% |
| 2017 Q4 | -0.53 SEK | -29.27% |
| 2016 Q4 | -1.08 SEK | -248.39% |
| 2016 Q1 | -0.96 SEK | -166.67% |
| 2016 FY | - SEK | -63.77% |
| 2016 Q2 | -0.36 SEK | 62.5% |
| 2016 Q3 | -0.31 SEK | 13.89% |
| 2015 FY | - SEK | 0.0% |
| 2015 Q4 | -0.36 SEK | 0.0% |
| 2011 FY | - SEK | 0.0% |